RESEARCHER PROFILE

Jörg H. W. Distler

← Back to Heinrich Heine University Düsseldorf

J

Heinrich Heine University Düsseldorf

Systemic Sclerosis and Related DiseasesDupuytren's Contracture and TreatmentsPulmonary Hypertension Research and TreatmentsConnective tissue disorders researchTGF-β signaling in diseases

Jörg H. W. Distler works in Systemic Sclerosis and Related Diseases, Dupuytren's Contracture and Treatments, Pulmonary Hypertension Research and Treatments, Connective tissue disorders research, TGF-β signaling in diseases. Recorded institutional associations include Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Düsseldorf University Hospital.

591Publications
42,792Citations
97H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    2016 · 5,856 citations
  2. Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study

    2021 · 5,035 citations
  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1

    2021 · 2,608 citations
  4. Update of EULAR recommendations for the treatment of systemic sclerosis

    2016 · 1,107 citations
  5. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

    2012 · 838 citations
  6. Mapping and predicting mortality from systemic sclerosis

    2017 · 691 citations
  7. Shared and distinct mechanisms of fibrosis

    2019 · 637 citations
  8. MicroRNA‐29, a key regulator of collagen expression in systemic sclerosis

    2010 · 539 citations
  9. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    2014 · 434 citations
  10. Angiogenic and angiostatic factors in the molecular control of angiogenesis.

    2003 · 398 citations
  11. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis

    2006 · 384 citations
  12. Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis

    2017 · 355 citations
  13. Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis

    2015 · 342 citations
  14. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles

    2005 · 328 citations
  15. Evidence of innate lymphoid cell redundancy in humans

    2016 · 320 citations
  16. Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis

    2004 · 312 citations
  17. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

    2020 · 310 citations
  18. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases

    2019 · 296 citations
  19. Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells

    2017 · 282 citations
  20. The Potential of Adiponectin in Driving Arthritis

    2006 · 278 citations
  21. Targeting TGF-β signaling for the treatment of fibrosis

    2018 · 274 citations
  22. Autophagy regulates TNFα-mediated joint destruction in experimental arthritis

    2012 · 269 citations
  23. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

    2016 · 268 citations
  24. Platelet-derived serotonin links vascular disease and tissue fibrosis

    2011 · 267 citations
  25. Overview of pathogenesis of systemic sclerosis

    2006 · 242 citations

← Return to the university profile